Discussion: A recent paper demonstrated that the
G1757A substitution is associated with protection against advanced
liver disease (P = 0.001).
Discussion: The low frequency of the
PC mutation could be explained by the high prevalence of the
G1757A mutation in our population.
Discussion: The low prevalence of the
PC/
BCP mutants in conjunction with the high percentage of the
G1757A mutation might influence the clinical characteristics of HBV/E.